Merit Med WRAPSODY Cell-Impermeable Endoprosthesis OKd by FDA

 

• Unique cell-impermeable1 design extends life-saving treatment for dialysis patients
• Merit to host a WRAPSODY informational call on January 28, 2025

Merit will host an informational conference call on Tuesday, January 28, 2025, at 4:30 p.m. Eastern (3:30 p.m. Central, 2:30 p.m. Mountain, and 1:30 p.m. Pacific) to discuss the forecasted opportunity the U.S. commercialization of WRAPSODY represents for the Company in the coming years.

To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details.

A live webcast can be accessed using this link. A link to both register for the conference call and view the webcast will be made available at merit.com.

A replay and summary materials from the presentation will also be available on the investor relations page of Merit’s website.

https://www.globenewswire.com/news-release/2024/12/20/3000656/8028/en/Merit-Medical-Announces-FDA-Approval-of-the-WRAPSODY-Cell-Impermeable-Endoprosthesis.html